Crescita Therapeutics Expands with Occy Assets Buy
Company Announcements

Crescita Therapeutics Expands with Occy Assets Buy

Crescita Therpeutc (TSE:CTX) has released an update.

Crescita Therapeutics Inc. has enhanced its market position by completing the acquisition of Occy Laboratory’s business assets, which includes manufacturing equipment, inventory, and intellectual property. The deal, valued at $0.9 million, is expected to be accretive to Crescita’s EBITDA following integration. Occy, facing bankruptcy proceedings, was approved for asset sale by the Québec Superior Court, and Crescita will maintain Occy’s commercial operations.

For further insights into TSE:CTX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskCrescita Therapeutics Sees Strong Q3 Revenue Growth
TipRanks Canadian Auto-Generated NewsdeskCrescita Therapeutics Positions for Growth Amid Q2 Challenges
TipRanks Canadian Auto-Generated NewsdeskCrescita Therapeutics Secures Lucrative Manufacturing Deal
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App